For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Regenxbio Inc’s stock clocked out at $8.75, up 4.04% from its previous closing price of $8.41. In other words, the price has increased by $4.04 from its previous closing price. On the day, 0.89 million shares were traded. RGNX stock price reached its highest trading level at $9.32 during the session, while it also had its lowest trading level at $8.62.
Ratios:
To gain a deeper understanding of RGNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.93 and its Current Ratio is at 2.93. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Mills Kenneth T. sold 20,602 shares for $7.91 per share. The transaction valued at 163,046 led to the insider holds 475,103 shares of the business.
KENNETH MILLS bought 20,602 shares of RGNX for $154,927 on May 12 ’25. On Dec 30 ’24, another insider, VITTAL VASISTA, who serves as the Officer of the company, bought 20,041 shares for $7.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 440901120 and an Enterprise Value of 304560064. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.81 while its Price-to-Book (P/B) ratio in mrq is 1.60. Its current Enterprise Value per Revenue stands at 1.943 whereas that against EBITDA is -2.154.
Stock Price History:
The Beta on a monthly basis for RGNX is 1.11, which has changed by -0.34259957 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, RGNX has reached a high of $15.02, while it has fallen to a 52-week low of $5.03. The 50-Day Moving Average of the stock is -2.62%, while the 200-Day Moving Average is calculated to be 4.12%.
Shares Statistics:
It appears that RGNX traded 997.06K shares on average per day over the past three months and 652260 shares per day over the past ten days. A total of 50.12M shares are outstanding, with a floating share count of 45.66M. Insiders hold about 9.38% of the company’s shares, while institutions hold 84.82% stake in the company. Shares short for RGNX as of 1752537600 were 6179816 with a Short Ratio of 6.20, compared to 1749772800 on 5512274. Therefore, it implies a Short% of Shares Outstanding of 6179816 and a Short% of Float of 14.899999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
